Mariko Shimizu Selected Research

glidobactin A

7/2010

Syrbactin class proteasome inhibitor-induced apoptosis and autophagy occurs in association with p53 accumulation and Akt/PKB activation in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mariko Shimizu Research Topics

Disease

5	Leukemia 03/2022 - 11/2014
2	Neoplasms (Cancer) 11/2022 - 11/2014
1	Graft vs Host Disease (Graft-Versus-Host Disease) 03/2022
1	Bone Marrow Failure Disorders 02/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2022
1	Juvenile Myelomonocytic Leukemia 02/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022
1	Fever (Fevers) 01/2022
1	Heart Arrest (Cardiac Arrest) 08/2021
1	Hypogonadism (Hypergonadotropic Hypogonadism) 05/2019
1	Medulloblastoma 01/2018
1	Philadelphia Chromosome 01/2018
1	Guillain-Barre Syndrome 01/2016
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2016
1	Epstein-Barr Virus Infections 02/2014
1	Ovarian Neoplasms (Ovarian Cancer) 07/2010
1	Neuroblastoma 07/2010
1	Multiple Myeloma 07/2010
1	Proteinuria 02/2009
1	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 02/2009
1	Nephrosis 02/2009
1	Obesity 06/2006

Drug/Important Bio-Agent (IBA)

2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 11/2014
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2022
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2022
1	Methotrexate (Mexate)FDA LinkGeneric 03/2022
1	Methylprednisolone FDA LinkGeneric 03/2022
1	InterleukinsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	NeopterinIBA 01/2022
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2022
1	Melphalan (Alkeran)FDA LinkGeneric 05/2019
1	Busulfan (Busulfex)FDA Link 05/2019
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	pirarubicinIBA 01/2016
1	Asparaginase (Elspar)FDA Link 01/2016
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Prednisone (Sone)FDA LinkGeneric 01/2016
1	Vincristine (Oncovin)FDA LinkGeneric 01/2016
1	Proteasome InhibitorsIBA 07/2010
1	glidobactin AIBA 07/2010
1	syringolin AIBA 07/2010
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 02/2009
1	Galectin 1 (LGALS1)IBA 02/2009
1	nephrinIBA 02/2009
1	Puromycin AminonucleosideIBA 02/2009
1	LeptinIBA 06/2006

Therapy/Procedure

4	Drug Therapy (Chemotherapy) 11/2022 - 02/2014
3	Transplantation 02/2022 - 11/2014
3	Hematopoietic Stem Cell Transplantation 01/2018 - 02/2014
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 03/2022
1	Cardiopulmonary Resuscitation (CPR) 08/2021
1	Resuscitation 08/2021
1	Cell Transplantation 05/2019
1	Craniospinal Irradiation 01/2018
1	Treatment Delay 01/2016
1	Aftercare (After-Treatment) 01/2016